Discovery of a novel 2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide M4 positive allosteric modulator (PAM) chemotype

Bioorg Med Chem Lett. 2020 Feb 1;30(3):126812. doi: 10.1016/j.bmcl.2019.126812. Epub 2019 Nov 13.

Abstract

This Letter details our efforts to discover structurally unique M4 PAMs containing 5,6-heteroaryl ring systems. In an attempt to improve the DMPK profiles of the 2,3-dimethyl-2H-indazole-5-carboxamide and 1-methyl-1H-benzo[d][1,2,3]triazole-6-carboxamide cores, we investigated a plethora of core replacements. This exercise identified a novel 2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide core that provided improved M4 PAM activity and CNS penetration.

Keywords: M(4); Muscarinic acetylcholine receptor; Positive allosteric modulator (PAM); Structure activity relationship (SAR).

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allosteric Regulation
  • Drug Design
  • Drug Evaluation, Preclinical
  • Humans
  • Imidazoles / chemistry*
  • Imidazoles / metabolism
  • Kinetics
  • Protein Binding
  • Pyrazines / chemistry*
  • Pyrazines / metabolism
  • Receptor, Muscarinic M4 / chemistry*
  • Receptor, Muscarinic M4 / metabolism
  • Structure-Activity Relationship

Substances

  • Imidazoles
  • Pyrazines
  • Receptor, Muscarinic M4
  • imidazo(1,5-a)pyrazine